技术与方法 |
|
|
|
|
大肠杆菌可溶性表达抗TNF-α Fab的工艺优化 |
张宇萌1,2, 童梅2, 陆小冬2, 米月1, 莫婷1,2, 刘金毅2, 姚文兵1 |
1 中国药科大学生命科学与技术学院 南京 210009;
2 北京三元基因药业股份有限公司 北京 102600 |
|
Expression of Soluble Anti-TNF-α Fab in E.coli: Optimization for Technological Process |
ZHANG Yu-meng1,2, TONG Mei2, LU Xiao-dong2, MI Yue1, MO Ting1,2, LIU Jin-yi2, YAO Wen-bing1 |
1 Institute of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China;
2 Beijing Tri-Prime Gene Pharmaceutical Co. Ltd., Beijing 102600, China |
引用本文:
张宇萌, 童梅, 陆小冬, 米月, 莫婷, 刘金毅, 姚文兵. 大肠杆菌可溶性表达抗TNF-α Fab的工艺优化[J]. 中国生物工程杂志, 2016, 36(9): 31-37.
ZHANG Yu-meng, TONG Mei, LU Xiao-dong, MI Yue, MO Ting, LIU Jin-yi, YAO Wen-bing. Expression of Soluble Anti-TNF-α Fab in E.coli: Optimization for Technological Process. China Biotechnology, 2016, 36(9): 31-37.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20160904
或
https://manu60.magtech.com.cn/biotech/CN/Y2016/V36/I9/31
|
[1] Tanaka Y. Current concepts in the management of rheumatoid arthritis. Korean J Intern Med, 2016, 31(2):210-218.
[2] Tanaka Y. Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis. Curr Opin Rheumatol, 2012, 24(3):319-326.
[3] Makrides S C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiology, 1996, 60(3):512-538.
[4] Olins P O, Lee S C. Recent advances in heterologous gene expression in Escherichia coli. Curr Opin Biotechnol, 1993, 4(5):520-525.
[5] 夏金兰,王晶,张倩,等. 嗜酸氧化亚铁硫杆菌ATCC23270周质蛋白的选择性提取及差异表达. 中南大学学报(自然科学版), 2009, 40(4):845-850. Xia J L, Wang J, Zhang Q, et al. Selective extraction and differential electrophoregrams analysis of periplasmic proteins of Acidithiobacillus ferrooxidans ATCC23270. Journal of Central South University(Science and Technology), 2009, 40(4):845-850.
[6] Kang H J, Kim H J, Cha S H, et al. Isolation of human anti-serum albumin Fab antibodies with an extended serum-half life. Immunology Letters, 2016, 169:33-40.
[7] Lakhrif Z, Pugnière M, Henriquet C, et al. A method to confer protein L binding ability to any antibody fragment. MAbs, 2016, 8(2):379-388.
[8] Graille M, Stura E A, Housden N G, et al. Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure, 2001, 9(8):679-687.
[9] 王清,蒋葵,李俊,等. 抗人大肠癌P-gp Fab抗体的制备、纯化及初步鉴定. 生物技术, 2013, 23(3):65-70. Wang Q, Jiang K, Li J, et al. Production,purification and identification of the Fab antibody against human colorectal cancer P-gp. Biotechnology, 2013, 23(3):65-70.
[10] Mayolo-Deloisa K, Lienqueo M E, Andrews B, et al. Hydrophobic interaction chromatography for purification of monoPEGylated RNase A. J Chromatogr A, 2012, 1242:11-1716.
[11] Mirani M R, Rahimpour F. Thermodynamic modelling of hydrophobic interaction chromatography of biomolecules in the presence of salt. J Chromatogr A, 2015, 1422:170-177.
[12] Murphy P J, Stone O J, Anderson M E. Automated hydrophobic interaction chromatography column selection for use in protein purification. J Vis Exp, 2011, 55(21):3060-3065.
[13] Arakawa T, Kita Y, Ejima D, et al. Solvent modulation of column chromatography. Protein Pept Lett, 2008, 15(6):544-555.
[14] Faust G, Janzen N H, Bendig C, et al. Feeding strategies enhance high cell density cultivation and protein expression in milliliter scale bioreactors. Biotechnology, 2014, 9(10):1293-1303.
[15] Velmurugan N, Kim H S, Jeong K J, et al. Enhanced production of human FccRⅡa receptor by high cell density cultivation of Escherichia coli. Protein Expression and Purification, 2011, 79(1):60-65. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|